These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 31322822
1. Emerging roles of exosomal miRNAs in breast cancer drug resistance. Najminejad H, Kalantar SM, Abdollahpour-Alitappeh M, Karimi MH, Seifalian AM, Gholipourmalekabadi M, Sheikhha MH. IUBMB Life; 2019 Nov; 71(11):1672-1684. PubMed ID: 31322822 [Abstract] [Full Text] [Related]
2. Exosomal microRNA: a novel biomarker for breast cancer. He Y, Deng F, Yang S, Wang D, Chen X, Zhong S, Zhao J, Tang J. Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358 [Abstract] [Full Text] [Related]
3. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner. Wang B, Zhang Y, Ye M, Wu J, Ma L, Chen H. Curr Drug Metab; 2019 Feb; 20(10):804-814. PubMed ID: 31424364 [Abstract] [Full Text] [Related]
4. MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes. Zhong S, Chen X, Wang D, Zhang X, Shen H, Yang S, Lv M, Tang J, Zhao J. Oncotarget; 2016 Apr 12; 7(15):19601-9. PubMed ID: 26910922 [Abstract] [Full Text] [Related]
5. Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells. Chen WX, Xu LY, Qian Q, He X, Peng WT, Zhu YL, Cheng L. Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30201690 [Abstract] [Full Text] [Related]
6. Role of exosomal microRNAs in lung cancer biology and clinical applications. Hu C, Meiners S, Lukas C, Stathopoulos GT, Chen J. Cell Prolif; 2020 Jun 21; 53(6):e12828. PubMed ID: 32391938 [Abstract] [Full Text] [Related]
7. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy. Rodríguez-Martínez A, de Miguel-Pérez D, Ortega FG, García-Puche JL, Robles-Fernández I, Exposito J, Martorell-Marugan J, Carmona-Sáez P, Garrido-Navas MDC, Rolfo C, Ilyine H, Lorente JA, Legueren M, Serrano MJ. Breast Cancer Res; 2019 Feb 06; 21(1):21. PubMed ID: 30728048 [Abstract] [Full Text] [Related]
8. Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review). Li H, Li X, Du W. Oncol Rep; 2024 Aug 06; 52(2):. PubMed ID: 38940326 [Abstract] [Full Text] [Related]
9. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities. Salehi M, Sharifi M. J Cell Physiol; 2018 Sep 06; 233(9):6370-6380. PubMed ID: 29323722 [Abstract] [Full Text] [Related]
10. Functional roles of exosomal miRNAs in multi-drug resistance in cancer chemotherapeutics. Mowla M, Hashemi A. Exp Mol Pathol; 2021 Feb 06; 118():104592. PubMed ID: 33296693 [Abstract] [Full Text] [Related]
11. Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs. Mao L, Li J, Chen WX, Cai YQ, Yu DD, Zhong SL, Zhao JH, Zhou JW, Tang JH. Tumour Biol; 2016 Apr 06; 37(4):5247-56. PubMed ID: 26555545 [Abstract] [Full Text] [Related]
14. Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1. Zhao Y, Jin LJ, Zhang XY. Aging (Albany NY); 2021 Jul 22; 13(14):18498-18514. PubMed ID: 34292880 [Abstract] [Full Text] [Related]
15. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs. Bahrami A, Aledavood A, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, Salarzaee O, ShahidSales S, Avan A. J Cell Physiol; 2018 Feb 22; 233(2):774-786. PubMed ID: 28109133 [Abstract] [Full Text] [Related]